EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial

Yixian Liu iD, Xiaoyu Li iD, Mengyu Zhang, Yuchun Men, Ying Wang, Xiaohong Zhu, Li Zheng iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s484310 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yixian Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China. Hauptthemen laut MEDLINE: Food-Drug Interactions, Protein Kinase Inhibitors, Protein-Tyrosine Kinases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food-Drug InteractionsProtein Kinase InhibitorsProtein-Tyrosine KinasesAdultFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralCross-Over StudiesFastingHealthy VolunteersTabletsTyrosine Kinase InhibitorsEast Asian People

Stichwörter der Autor:innen

##Food effectsHA121-28pharmacokineticssafetytyrosine kinase inhibitor

Substanzen

Protein Kinase InhibitorsProtein-Tyrosine KinasesTabletsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
  • Clinical Trial Center, NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

ORCID-Profile: Yixian Liu, Xiaoyu Li, Li Zheng

Zitieren

APA

Liu, Y., Li, X., Zhang, M., Men, Y., Wang, Y., Zhu, X., & Zheng, L. (2025). Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s484310

Vancouver

Liu Y, Li X, Zhang M, Men Y, Wang Y, Zhu X, et al. Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s484310

BibTeX
@article{Liu2025,
  author = {Liu, Yixian and Li, Xiaoyu and Zhang, Mengyu and Men, Yuchun and Wang, Ying and Zhu, Xiaohong and Zheng, Li},
  title = {Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s484310}
}
Kostenlos starten →